Literature DB >> 21701071

Intestinal carcinogenesis: IKK can go all the way.

Yoshiaki Sunami1, Thomas Wirth.   

Abstract

Chronic inflammation has long been suspected to support tumorigenesis in a variety of cancers. The IκB kinase (IKK)/NF-κB pathway is the critical signal transduction pathway regulating inflammation, and loss-of-function studies have demonstrated its involvement in tumorigenesis. In this issue of the JCI, Vlantis et al. present evidence that persistent genetic activation of IKK/NF-κB signaling in intestinal epithelial cells not only accelerates tumorigenesis in models of both carcinogen- and mutation-induced colorectal cancer, but also is sufficient to induce intestinal tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701071      PMCID: PMC3223848          DOI: 10.1172/JCI58454

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

Review 1.  Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

Authors:  Michael Karin; Toby Lawrence; Victor Nizet
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 2.  APC, signal transduction and genetic instability in colorectal cancer.

Authors:  R Fodde; R Smits; H Clevers
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

3.  Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice.

Authors:  Katerina Vlantis; Andy Wullaert; Yoshiteru Sasaki; Marc Schmidt-Supprian; Klaus Rajewsky; Tania Roskams; Manolis Pasparakis
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

4.  Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis.

Authors:  R Smits; A Kartheuser; S Jagmohan-Changur; V Leblanc; C Breukel; A de Vries; H van Kranen; J H van Krieken; S Williamson; W Edelmann; R Kucherlapati; R Fodde
Journal:  Carcinogenesis       Date:  1997-02       Impact factor: 4.944

5.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

6.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

7.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

8.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

Authors:  Y Miyoshi; H Nagase; H Ando; A Horii; S Ichii; S Nakatsuru; T Aoki; Y Miki; T Mori; Y Nakamura
Journal:  Hum Mol Genet       Date:  1992-07       Impact factor: 6.150

Review 9.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

10.  Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine.

Authors:  Blair B Madison; Laura Dunbar; Xiaotan T Qiao; Katherine Braunstein; Evan Braunstein; Deborah L Gumucio
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  5 in total

1.  Long non-coding RNA NKILA serves as a biomarker in the early diagnosis and prognosis of patients with colorectal cancer.

Authors:  Peng Jiang; Xiaoting Han; Yingnan Zheng; Jianchao Sui; Weiping Bi
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

Review 2.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

Review 3.  p53 and the Carcinogenicity of Chronic Inflammation.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

Review 4.  NF-κB in colorectal cancer.

Authors:  Aristeidis G Vaiopoulos; Kalliopi Ch Athanasoula; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

Review 5.  Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism.

Authors:  Srabani Pal; Ashish Bhattacharjee; Asif Ali; Narayan C Mandal; Subhash C Mandal; Mahadeb Pal
Journal:  J Inflamm (Lond)       Date:  2014-08-09       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.